NPPA notified regarding the fixation of the Atorvastatin calcium IP eq. to Atorvastatin 20 mg + Clopidogrel bisulphate IP e.q. to Clopidogrel 75 mg for M/s Pure and Cure Healthcare Pvt. Ltd

Feb 20, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific Complianceclass="MsoNormal" style="text-align: justify;">The National Pharmaceutical Pricing Authority (NPPA) on February 19, 2025, notified regarding the fixation of the retail price of Atorvastatin calcium IP eq. to Atorvastatin 20 mg + Clopidogrel bisulphate IP e.q. to Clopidogrel 75 mg for M/s Pure and Cure Healthcare Pvt. Ltd.

It has fixed the rate at Rs. 18.76/- for each uncoated bilayered tablet containing: Atorvastatin calcium IP eq. to Atorvastatin 20 mg + Clopidogrel bisulphate IP e.q. to Clopidogrel 75 mg.

[Notification no. - 19(4445)/2025/DP/NPPA/Div.II]

View Document 1

Bookmark

Related Updates

View More Related Updates


Alternate Text

Get updates on the go on RegUpdate Mobile App.

Alternate Text
✦ NEW  ·  AI ASSISTANT